Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/30/26
Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026PRNewsWire • 07/23/26
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For TuesdayBenzinga • 07/21/26
Billionaire Investor Stanley Druckenmiller's Top 5 Picks: Worth Buying Today?24/7 Wall Street • 07/20/26
Insmed Incorporated (INSM) Discusses 12-Month Results From Ongoing TPIP Open-Label Extension Study in PAH Patients TranscriptSeeking Alpha • 07/16/26
Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial HypertensionPRNewsWire • 07/16/26
EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in BronchiectasisGlobeNewsWire • 06/25/26
Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global RespiratoryPRNewsWire • 06/23/26
Insmed: Extensive Phase 3 TPIP Program And Revenue Growth In Q1 2026, Strong BuySeeking Alpha • 06/22/26
Insmed Incorporated (INSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/09/26
Insmed Incorporated (INSM) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/20/26
Insmed Incorporated (INSM) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/12/26
Insmed Tanks On Its Most Important Launch; Why Analysts Remain BullishInvestors Business Daily • 05/07/26